Key Highlights

  • SL Science Holding (NASDAQ:SLBT) traded about 11.30% lower, near USD 1.02, in early trading on Monday, October 26, 2026, with no company release explaining the move.
  • The company, formerly SL BIO Ltd., completed a business combination with Horizon Space Acquisition II Corp. and lists on the Nasdaq Global Market under the symbol SLBT.
  • A company release of Wednesday, September 2, 2026 marked its first quarter as a publicly traded company, and a later prospectus covered the resale of about 1.04 million shares.
  • Market data indicate that the shares fell about 19.6% over the 30 days before this session, so Monday's decline extends an existing downtrend.

A Post-Merger Share Price Under Pressure

SL Science Holding (NASDAQ:SLBT) is a pharmaceuticals and biotechnology company that began trading on the Nasdaq Global Market after a business combination with Horizon Space Acquisition II Corp., a special purpose acquisition company, or SPAC. Its shares traded about 11.30% lower, near USD 1.02, in early trading on Monday, October 26, 2026. The company has not issued a release explaining the move. Its release of Wednesday, September 2, 2026 described the end of an active first quarter as a public company, including the ringing of the Nasdaq bell. Market data show a decline of about 19.6% in the 30 days before this session, and a price near USD 1.02 is far below the USD 10 trust value at which SPAC shares normally begin.

Why De-SPAC Shares Often Slide

A de-SPAC is a company that goes public by merging with a SPAC, and its shares often fall after closing. Holders who redeemed at about USD 10 per share leave a small free float, which is the part of the shares available to public traders, and sponsors and former owners may later sell shares. SL Science Holding (NASDAQ:SLBT) filed a prospectus under Rule 424(b)(3) to register the resale of about 1.04 million shares, which adds potential supply even though it is small in number. Thin liquidity then magnifies each sale, so an 11.30% move can occur without news. The company has not disclosed the share count behind Monday's price, and the price level shown for Monday is itself a market snapshot.

Risks and What to Watch

The first risk for SL Science Holding (NASDAQ:SLBT) is a minimum bid price deficiency: Nasdaq requires a closing bid of at least USD 1.00, and the shares are trading close to that level. A notice would start a 180-day cure period and could lead to a reverse split, meaning a consolidation of shares into fewer, higher-priced ones. The second risk is dilution from resale registrations and future financing. The third is limited public information on revenue and cash. Investors should watch any exchange compliance notice, filings on Form 6-K from the foreign private issuer, the next resale or financing announcement and the Federal Reserve decision on Wednesday, October 28, 2026.

Where Things Stand

The answer is that SL Science Holding (NASDAQ:SLBT) fell 11.30% in early trading on Monday, October 26, 2026 most likely because of the post-merger pattern of thin liquidity and share supply, since the company has announced no catalyst. That explanation is an inference from the share structure and prior weakness. The price near USD 1.02 leaves little room above the exchange minimum bid. The next catalysts are any compliance notice, new regulatory filings and the Federal Reserve decision on October 28, 2026. Post-merger shares are volatile, and this is not investment advice.